US Patent Issued to The General Hospital on April 14 for "Salt inducible kinase inhibitors" (New Jersey, Massachusetts Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,719, issued on April 14, was assigned to The General Hospital Corp. (Boston).

"Salt inducible kinase inhibitors" was invented by Marc Nathan Wein (Wellesley, Mass.) and William J. Greenlee (Teaneck, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides compounds that modulate the activity of one or more salt inducible kinases (SIKs). Pharmaceutical composition and methods of treating diseases associated with abnormal expression and/or activity of one or more SIKs are also provided."

The patent was filed on Aug. 5, 2021, under Application No. 18/019,527.

*For further information, including images, charts and tables, ...